Related Experiment Video
Updated: Aug 8, 2026
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Does prophylactic sotalol and magnesium decrease the incidence of atrial fibrillation following coronary artery
V Aerra1, M Kuduvalli, A N Moloto
1Department of Cardiothoracic Surgery, The Cardiothoracic Centre Liverpool, UK. vikram.aerra@gmail.com
Insights
Sotalol and magnesium significantly reduce the incidence of post-operative atrial fibrillation in coronary surgery patients. This combination therapy offers a promising strategy for improving outcomes after cardiac procedures.
Area of Science:
- Cardiology
- Cardiac Surgery
- Pharmacology
Background:
- Post-operative atrial fibrillation (POAF) is a common complication following coronary surgery, affecting up to 40% of patients.
- POAF can lead to increased morbidity, mortality, and healthcare costs.
Purpose of the Study:
- To evaluate the efficacy of a combination therapy with sotalol and magnesium in reducing the incidence of POAF after coronary surgery.
Main Methods:
- A retrospective analysis of 103 coronary surgery patients was conducted.
- Patients received either sotalol and magnesium or no treatment (control group).
- Propensity score matching was used to create comparable groups of 89 patients each.
Main Results:
- The incidence of atrial fibrillation was significantly lower in the sotalol and magnesium group (13.5%) compared to the control group (27.0%) (p = 0.025).
- No significant difference in in-hospital mortality was observed between the groups.
Conclusions:
- The combination of sotalol and magnesium is effective in significantly reducing the incidence of post-operative atrial fibrillation after coronary surgery.
- This therapeutic approach may improve patient outcomes following cardiac procedures.
Background:
Atrial fibrillation can occur in up to 40% of patients undergoing coronary surgery.
Methods:
We retrospectively analysed 103 consecutive coronary surgery patients under the care of one surgeon between April 2003 and September 2003. These patients received 40 mg of sotalol orally twice daily from the first post-operative day for 6 weeks and 2 g of magnesium intravenously immediately post surgery and on the first post-operative day. We developed a propensity score for the probability of receiving sotalol and magnesium after coronary surgery. 89 patients from the sotalol and magnesium group were successfully matched with 89 unique coronary surgery patients who did not receive either sotalol or magnesium with an identical propensity score.
Results:
Preoperative characteristics were well matched between groups. There was no significant difference with respect to in-hospital mortality between groups (sotalol and magnesium 1.1% versus control 4.5%; p = 0.17). The incidence of atrial fibrillation in the sotalol and magnesium group was 13.5% compared to 27.0% in the controls (p = 0.025).
Conclusion:
The combination of sotalol and magnesium can significantly reduce the incidence of post-operative atrial fibrillation following coronary surgery.
Related Concept Videos
01:25Dysrhythmias VI: Management of Dysrhythmias
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management